WallStreetZenWallStreetZen

NASDAQ: NUVL
Nuvalent Inc Stock Ownership - Who owns Nuvalent?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Nuvalent Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Deborah Ann MillerChief Legal Officer2026-04-305,500$6.89
$37.90kBuy
Deborah Ann MillerChief Legal Officer2026-04-301,082$99.57
$107.73kSell
Deborah Ann MillerChief Legal Officer2026-04-304,418$99.13
$437.96kSell
Darlene NociChief Development Officer2026-04-29700$100.14
$70.10kSell
Darlene NociChief Development Officer2026-04-29300$101.17
$30.35kSell
Darlene NociChief Development Officer2026-04-295,500$27.85
$153.18kBuy
Darlene NociChief Development Officer2026-04-294,500$99.35
$447.08kSell
Henry E. PelishChief Scientific Officer2026-04-09900$105.00
$94.50kSell
Henry E. PelishChief Scientific Officer2026-04-092,193$104.27
$228.66kSell
Henry E. PelishChief Scientific Officer2026-04-093,093$27.85
$86.14kBuy

1 of 29

NUVL insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NUVL insiders and whales buy or sell their stock.

NUVL Shareholders

What type of owners hold Nuvalent Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
James E. Flynn22.77%17,903,448$1.77BInsider
Deerfield Management Company LP21.94%17,248,450$1.71BInstitution
Fmr LLC13.80%10,852,884$1.07BInstitution
Paradigm Biocapital Advisors LP6.70%5,269,433$521.88MInstitution
Vanguard Group Inc6.67%5,244,271$519.39MInstitution
Blackrock Inc6.11%4,805,261$475.91MInstitution
Wellington Management Group LLP3.13%2,461,823$243.82MInstitution
Jpmorgan Chase Co2.81%2,205,251$218.41MInstitution
Price T Rowe Associates Inc2.73%2,146,938$212.63MInstitution
Ra Capital Management LP2.39%1,880,057$186.20MInstitution

1 of 3

NUVL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NUVL77.47%22.53%Net SellingNet Selling
KRYS80.01%19.99%Net SellingNet Selling
CYTK90.01%9.99%Net SellingNet Selling
HALO78.05%21.95%Net SellingNet Selling
PCVX88.01%11.99%Net SellingNet Selling
View Top Biotech Stocks

Nuvalent Stock Ownership FAQ

Who owns Nuvalent?

Nuvalent (NASDAQ: NUVL) is owned by 101.64% institutional shareholders, 29.56% Nuvalent insiders, and 0.00% retail investors. James E. Flynn is the largest individual Nuvalent shareholder, owning 17.90M shares representing 22.77% of the company. James E. Flynn's Nuvalent shares are currently valued at $1.77B.

If you're new to stock investing, here's how to buy Nuvalent stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.